المؤلفون: Jurczyszyn, Artur, Radocha, Jakub, Davila, Julio, Fiala, Mark A, Gozzetti, Alessandro, Grząśko, Norbert, Robak, Paweł, Hus, Iwona, Waszczuk-Gajda, Anna, Guzicka-Kazimierczak, Renata, Atilla, Erden, Mele, Giuseppe, Sawicki, Waldemar, Jayabalan, David S, Charliński, Grzegorz, Szabo, Agoston G, Hajek, Roman, Delforge, Michel, Kopacz, Agnieszka, Fantl, Dorotea, Waage, Anders, Avivi, Irit, Rodzaj, Marek, Leleu, Xavier, Richez, Valentine, Knopińska-Posłuszny, Wanda, Masternak, Anna, Yee, Andrew J, Barchnicka, Agnieszka, Druzd-Sitek, Agnieszka, Guerrero-Garcia, Thomas, Liu, Jieqi, Vesole, David H, Castillo, Jorge J

المساهمون: Jurczyszyn, Artur, Radocha, Jakub, Davila, Julio, Fiala, Mark A, Gozzetti, Alessandro, Grząśko, Norbert, Robak, Paweł, Hus, Iwona, Waszczuk-Gajda, Anna, Guzicka-Kazimierczak, Renata, Atilla, Erden, Mele, Giuseppe, Sawicki, Waldemar, Jayabalan, David S, Charliński, Grzegorz, Szabo, Agoston G, Hajek, Roman, Delforge, Michel, Kopacz, Agnieszka, Fantl, Dorotea, Waage, Ander, Avivi, Irit, Rodzaj, Marek, Leleu, Xavier, Richez, Valentine, Knopińska-Posłuszny, Wanda, Masternak, Anna, Yee, Andrew J, Barchnicka, Agnieszka, Druzd-Sitek, Agnieszka, Guerrero-Garcia, Thoma, Liu, Jieqi, Vesole, David H, Castillo, Jorge J

مصطلحات موضوعية: myeloma, plasma cell leukaemia, prognosi, survival, therapeutic response

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29315478; info:eu-repo/semantics/altIdentifier/wos/WOS:000426607200008; volume:180; issue:6; firstpage:831; lastpage:839; numberofpages:9; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/11365/1063215Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042936275

الإتاحة: https://doi.org/10.1111/bjh.15092Test
http://hdl.handle.net/11365/1063215Test

المؤلفون: Kim, E. Bridget¹ (AUTHOR) ebkim@partners.org, Yee, Andrew J.^2,3 (AUTHOR) ayee1@mgh.harvard.edu, Raje, Noopur^2,3 (AUTHOR) nraje@mgh.harvard.edu

المصدر: Cancers. May2020, Vol. 12 Issue 5, p1223. 1p.

مصطلحات موضوعية: *MULTIPLE myeloma treatment, *MULTIPLE myeloma, *RISK assessment, *SURVIVAL, *DISEASE progression, *EARLY medical intervention, *DISEASE risk factors